Which has the lower trailing P/E, GSK or MDT?

GSK has the lower trailing P/E: GSK trades at 16.49 and MDT at 23.97. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GSK or MDT?

Over the past five years, MDT grew revenue faster — GSK at a 1.38% CAGR versus MDT at 5.18%.

Does GSK or MDT pay a bigger dividend?

GSK yields 3.44% and MDT yields 3.19% based on trailing dividends and the latest price.

Is GSK or MDT more profitable?

GSK runs the higher net margin — GSK at 14.52% versus MDT at 13.20%.

How have GSK and MDT total returns compared?

Over the past 10 years, GSK delivered 6.47% and MDT delivered 2.94% annualized total return. Past performance doesn't predict future results.

GSK plc (GSK) vs Medtronic plc (MDT)

A side-by-side comparison of GSK plc and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

GSK

GSK plc

$101.98B

$50.90HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

MDT

Medtronic plc

$116.07B

$90.68HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

Total return — GSK vs MDT

growth of $100 · dividends reinvested · last 10y

GSK +88.1% (+6.5%/yr)MDT +33.8% (+3.0%/yr)GSK compounded faster over this window

GSK MDT

GSK vs MDT: by the numbers

•MDT is the larger company ($116.07B vs $101.98B market cap).
•GSK trades at the lower trailing earnings multiple (16.49 vs 23.97 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 13.20% net margin).
•MDT grew revenue faster over the past five years (5.18% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.44% vs 3.19%).

Metrics side by side

Valuation

Metric	GSK	MDT
P/E ratio	16.49	23.97
Forward P/E	14.58	16.20
P/S ratio	2.39	3.17
P/B ratio	4.56	2.33
EV / EBITDA	8.46	15.13
FCF yield	8.80%	4.71%

Profitability

Metric	GSK	MDT
Gross margin	72.71%	65.02%
Operating margin	20.72%	17.78%
Net margin	14.52%	13.20%
ROE	27.67%	9.70%
ROIC	16.61%	6.13%

Dividends

Metric	GSK	MDT
Dividend yield	3.44%	3.19%
Payout ratio	47.32%	76.00%

Growth (annualized)

Metric	GSK	MDT
Revenue CAGR (5Y)	1.38%	5.18%
EPS CAGR (5Y)	-0.71%	6.97%
FCF CAGR (5Y)	-2.45%	3.07%
Total return CAGR (5Y)	9.56%	-3.56%

Frequently asked

Which has the lower trailing P/E, GSK or MDT?: GSK has the lower trailing P/E: GSK trades at 16.49 and MDT at 23.97. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GSK or MDT?: Over the past five years, MDT grew revenue faster — GSK at a 1.38% CAGR versus MDT at 5.18%.
Does GSK or MDT pay a bigger dividend?: GSK yields 3.44% and MDT yields 3.19% based on trailing dividends and the latest price.
Is GSK or MDT more profitable?: GSK runs the higher net margin — GSK at 14.52% versus MDT at 13.20%.
How have GSK and MDT total returns compared?: Over the past 10 years, GSK delivered 6.47% and MDT delivered 2.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full MDT analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio Medtronic P/E ratio GSK dividend yield Medtronic dividend yield GSK ROE Medtronic ROE GSK operating margin Medtronic operating margin GSK revenue growth Medtronic revenue growth GSK free cash flow Medtronic free cash flow

GSK & Medtronic appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.